For example, treatment with synaptamide in traumatic brain injury or sciatic nerve chronic constriction injury decreased astrogliosis and immunoreactivity and reduced the levels of inflammatory biomarkers such as glial fibrillary acidic protein (GFAP), S100β, and IL-6 [25,26,27,28]. Here, S100B is linked to injury.